Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuo Therapeutics Inc (NUOT)

Nuo Therapeutics Inc (NUOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuo Therapeutics Inc 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD 20877

www.nuot.com P: 240-499-2680

Description:

Nuo Therapeutics, Inc. is a biomedical company. It commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company has two distinct platelet rich plasma devices, the AutoloGel (TM) System for wound care and the Angel (TM) concentrated Platelet Rich Plasma System for orthopedics markets. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates. Nuo Therapeutics, Inc., formerly known as Cytomedix, Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 1,390
Shares Outstanding, K 125,680
Annual Sales, $ 7,760 K
Annual Net Income, $ -18,880 K
Last Quarter Sales, $ 2,170 K
Last Quarter Net Income, $ -13,830 K
60-Month Beta -0.68
% of Insider Shareholders 13.60%
% of Institutional Shareholders 0.02%

Growth:

1-Year Return -95.47%
3-Year Return -97.93%
5-Year Return -96.78%
5-Year Revenue Growth 274.88%
5-Year Earnings Growth 50.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/15
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 20.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NUOT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -19.26%
Return-on-Assets % -6.63%
Profit Margin % -243.30%
Debt/Equity 0.00
Price/Sales 3.05
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 0.04
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar